[Federal Register Volume 62, Number 98 (Wednesday, May 21, 1997)]
[Notices]
[Pages 27775-27776]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 97-13311]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Importation of Controlled Substances; Notice of Application
Pursuant to Section 1008 of the Controlled Substance Import and
Export Act (21 U.S.C. 958(i)), the Attorney General shall, prior to
issuing a registration under this Section to a bulk manufacturer of a
controlled substance in Schedule I or II and prior to issuing a
regulation under Section 1002(a) authorizing the importation of such a
substance, provide manufacturers holding registrations for the bulk
manufacture of the substance an opportunity for a hearing.
Therefore, in accordance with Section 1311.42 of Title 21, Code of
Federal
[[Page 27776]]
Regulations (CFR), notice is hereby given that on March 17, 1997,
Research Biochemicals, Limited Partnership, 1-3 Strathmore Road,
Natick, Massachusetts 01760, made application to the Drug Enforcement
Administration to be registered as an importer to the basic classes of
controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Methaqualone (2565)...................... I
Ibogaine (7260).......................... I
Tetrahydrocannabinols (7370)............. I
Bufotenine (7433)........................ I
Dimethyltryptamine (7435)................ I
Etorphine (except HCl) (9056)............ I
Methylphenidate (1724)................... II
Pentobarbital (2270)..................... II
Diprenorphine (9058)..................... II
Etorphine Hydrochloride (9059)........... II
Diphenoxylate (9170)..................... II
Metazocine (9240)........................ II
Methadone (9250)......................... II
Fentanyl (9801).......................... II
------------------------------------------------------------------------
The firm plans to import small quantities of the listed controlled
substances to manufacture laboratory reference standards and
neurochemicals.
Any manufacturer holding, or applying for, registration as a bulk
manufacturer of these basic classes of controlled substances may file
written comments on or objections to the application described above
and may, at the same time, file a written request for a hearing on such
application in accordance with 21 CFR 1301.54 in such form as
prescribed by 21 CFR 1316.47.
Any such comments, objections, or requests for a hearing may be
addressed, in quintuplicate, to the Acting Deputy Assistant
Administrator, Office of Diversion Control, Drug Enforcement
Administration, United States Department of Justice, Washington, D.C.
20537, Attention: DEA Federal Register Representative (CCR), and must
be filed no later than (30 days from publication).
This procedure is to be conducted simultaneously with and
independent of the procedures described in 21 CFR 1311.42 (b), (c),
(e), and (f). As noted in a previous notice at 40 FR 43745-46
(September 23, 1975), all applicants for registration to import basic
classes of any controlled substances in Schedule I or II are and will
continue to be required to demonstrate to the Acting Deputy Assistant
Administrator, Office of Division Control, Drug Enforcement
Administration that the requirements for such registration pursuant to
21 U.S.C. 958(a), 21 U.S.C. 823(a), and 21 CFR 1311.42 (a), (b), (c),
(d), (e), and (f) are satisfied.
Dated: April 24, 1997.
Terrance W. Woodworth,
Acting Deputy Assistant Administrator, Office of Diversion Control,
Drug Enforcement Administration.
[FR Doc. 97-13311 Filed 5-20-97; 8:45 am]
BILLING CODE 4410-09-M
